Hypertension Trial, Recruiting NCT05955339 Sponsor: Dartmouth-Hitchcock Medical Center Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05955339
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • People aged 65 years or older
  • People living with multiple health conditions — specifically, diabetes or high blood pressure, plus at least one other condition from this list: arthritis (osteoarthritis or rheumatoid arthritis), asthma, irregular heartbeat (atrial fibrillation), mild Alzheimer's disease or related memory conditions, cancer, chronic obstructive pulmonary disease (COPD), depression, heart disease, heart failure, high cholesterol, osteoporosis, kidney disease, or stroke — people with both diabetes and high blood pressure also meet this condition
  • People who have had two or more visits to their clinic in the past 12 months
  • People who plan to continue receiving care at the same clinic with the same doctor for at least the next 6 months
  • People who do not have vision or hearing problems that cannot be corrected with glasses, hearing aids, or similar supports
  • People who have not recorded a clinic visit for personal use in the past 6 months (confirm with trial site)

For caregivers:

  • People who agree to their role as a caregiver for a participating patient
  • People who speak English or Spanish
  • People who have the ability to give informed consent to take part in research
  • People aged 18 years or older

Who may not be able to join:

For patients:

  • People who do not have the mental capacity to give consent to participate
  • People diagnosed with schizophrenia, other psychotic disorders, or a current substance use disorder
  • People with uncorrected hearing or vision problems that cannot be supported or accommodated for the purposes of the study
  • People currently living in a skilled nursing home or hospice care
  • People identified as having significant cognitive impairment based on a short memory screening test (a score of 4 or below on the six-item screener)
  • People without access to the internet
  • People who do not speak English or Spanish
  • People who do not have a personal email address, do not have an email shared with a family member or carer, and are not willing to create one, as this would prevent engagement with the study activities
  • People who are unwilling to create an online patient portal account if they do not already have one, as this would prevent engagement with the study activities

For caregivers:

  • People who do not have the mental capacity to give consent to participate
  • People currently living in a skilled nursing home or hospice care
  • People without access to the internet
  • People who do not speak English or Spanish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paul J Barr, PhD, Dartmouth College

Phone: 603-646-7016

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 January 2024
Est. completion
7 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Quality of Life - Mental functioning; Quality of Life - Physical functioning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov